ClinVar Miner

Submissions for variant NM_000466.3(PEX1):c.3419_3424del (p.Asn1140_Gly1141del)

dbSNP: rs758076338
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000732861 SCV000860857 uncertain significance not provided 2018-04-10 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001247717 SCV001421157 uncertain significance Zellweger spectrum disorders 2025-01-13 criteria provided, single submitter clinical testing This variant, c.3419_3424del, results in the deletion of 2 amino acid(s) of the PEX1 protein (p.Asn1140_Gly1141del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs758076338, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with PEX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 596889). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital RCV001731913 SCV001984006 uncertain significance not specified 2020-05-14 criteria provided, single submitter clinical testing
Breakthrough Genomics, Breakthrough Genomics RCV000732861 SCV005195966 uncertain significance not provided criteria provided, single submitter not provided
GeneDx RCV000732861 SCV005386363 uncertain significance not provided 2024-01-12 criteria provided, single submitter clinical testing In-frame deletion of 2 amino acids in a non-repeat region; In silico analysis supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000732861 SCV001951562 uncertain significance not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000732861 SCV001967800 uncertain significance not provided no assertion criteria provided clinical testing
Natera, Inc. RCV001247717 SCV002076811 uncertain significance Zellweger spectrum disorders 2018-05-09 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV003396307 SCV004103764 uncertain significance PEX1-related disorder 2024-05-22 no assertion criteria provided clinical testing The PEX1 c.3419_3424del6 variant is predicted to result in an in-frame deletion (p.Asn1140_Gly1141del). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.10% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/7-92120599-GTTCCAT-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.